GLP-1(7-37)

• CAT Number: P000029
• CAS Number: 106612-94-6
• Molecular Formula: C151H228N40O47
• Molecular Weight: 3355.67
• Purity: 98%
• Synonyms: GLP-1 (7-37) peptide; Glucagon like Peptide-1 (7-37) Acetate. Insulinotropin. Tglp-1.;His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-Gly, tetracetate
• Target: GCGR
• Solubility: H2O
• Appearance: Solid powder
• Storage: Store at -20°C
• SMILES: O=C(N[C@@H](C)C(N[C@@H](CCC(O)=O)C(NCC(N[C@@H]([C@H](O)C)C(N[C@@H](CC1=CC=CC=C1)C(N[C@@H]([C@H](O)C)C(N[C@@H](CO)C(N[C@@H](CC(O)=O)C(N[C@@H](C(C)C)C(N[C@@H](CO)C(N[C@@H](CO)C(N[C@@H](CC2=CC=C(C=C2)O)C(N[C@@H](CC(C)C)C(N[C@@H](CCC(O)=O)C(NCC(N[C@@H](CCC(N)

GLP-1(7-37), or glucagon-like peptide-1 (7-37), is an active form of the GLP-1 hormone that plays a critical role in glucose metabolism and insulin regulation. It is a 31-amino acid peptide hormone derived from the larger proglucagon molecule and acts primarily by enhancing insulin secretion in a glucose-dependent manner, inhibiting glucagon release, slowing gastric emptying, and promoting satiety. These properties make GLP-1(7-37) a focus of research in the treatment of type 2 diabetes and obesity. Its ability to regulate blood glucose levels without causing hypoglycemia has led to the development of GLP-1 receptor agonists as therapeutic agents for metabolic disorders.